LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MCF7 | AZD8055 | 0.04 | uM | LJP6 | 3 | A12 | 72 | hr | 1389 | 1466 | 5740 | 0.2554 | 0.0267 |
| MCF7 | AZD8055 | 3.33 | uM | LJP6 | 3 | A08 | 72 | hr | 1389 | 1575 | 5740 | 0.2744 | 0.0633 |
| MCF7 | AZD7762 | 0.37 | uM | LJP6 | 3 | L04 | 72 | hr | 1389 | 1619 | 5740 | 0.2820 | 0.0777 |
| MCF7 | AZD7762 | 10 | uM | LJP6 | 3 | L01 | 72 | hr | 1389 | 863 | 5740 | 0.1503 | -0.2075 |
| MCF7 | AZD8055 | 0.12 | uM | LJP6 | 3 | A11 | 72 | hr | 1389 | 1485 | 5740 | 0.2587 | 0.0332 |
| MCF7 | AZD8055 | 1.11 | uM | LJP6 | 3 | A09 | 72 | hr | 1389 | 1705 | 5740 | 0.2970 | 0.1053 |
| MCF7 | AZD7762 | 0.04 | uM | LJP6 | 3 | L06 | 72 | hr | 1389 | 1929 | 5740 | 0.3360 | 0.1740 |
| MCF7 | AT-7519 | 3.33 | uM | LJP6 | 3 | K02 | 72 | hr | 1389 | 472 | 5740 | 0.0822 | -0.4098 |
| MCF7 | AZD7762 | 1.11 | uM | LJP6 | 3 | L03 | 72 | hr | 1389 | 1326 | 5740 | 0.2310 | -0.0224 |
| MCF7 | AZD7762 | 3.33 | uM | LJP6 | 3 | L02 | 72 | hr | 1389 | 1122 | 5740 | 0.1955 | -0.0990 |
| MCF7 | AZD7762 | 0.12 | uM | LJP6 | 3 | L05 | 72 | hr | 1389 | 1675 | 5740 | 0.2918 | 0.0958 |
| MCF7 | Seliciclib | 10 | uM | LJP5 | 3 | J01 | 72 | hr | 1389 | 1407 | 6038 | 0.2330 | 0.0061 |
| MCF7 | AZD8055 | 0.37 | uM | LJP6 | 3 | A10 | 72 | hr | 1389 | 1578 | 5740 | 0.2749 | 0.0643 |
| MCF7 | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 1389 | 5080 | 5740 | 0.8849 | 0.8841 |
| MCF7 | Seliciclib | 1.11 | uM | LJP5 | 3 | J03 | 72 | hr | 1389 | 5578 | 6038 | 0.9237 | 0.9266 |
| MCF7 | Seliciclib | 0.37 | uM | LJP5 | 3 | J04 | 72 | hr | 1389 | 6206 | 6038 | 1.0277 | 1.0260 |
| MCF7 | AT-7519 | 0.12 | uM | LJP6 | 3 | K05 | 72 | hr | 1389 | 2662 | 5740 | 0.4637 | 0.3740 |
| MCF7 | Seliciclib | 0.12 | uM | LJP5 | 3 | J05 | 72 | hr | 1389 | 6115 | 6038 | 1.0127 | 1.0119 |
| MCF7 | Seliciclib | 3.33 | uM | LJP5 | 3 | J02 | 72 | hr | 1389 | 5104 | 6038 | 0.8452 | 0.8475 |
| MCF7 | AT-7519 | 0.37 | uM | LJP6 | 3 | K04 | 72 | hr | 1389 | 790 | 5740 | 0.1376 | -0.2410 |
| MCF7 | Seliciclib | 0.04 | uM | LJP5 | 3 | J06 | 72 | hr | 1389 | 6077 | 6038 | 1.0064 | 1.0060 |
| MCF7 | AT-7519 | 10 | uM | LJP6 | 3 | K01 | 72 | hr | 1389 | 324 | 5740 | 0.0564 | -0.5089 |
| MCF7 | AT-7519 | 1.11 | uM | LJP6 | 3 | K03 | 72 | hr | 1389 | 640 | 5740 | 0.1115 | -0.3152 |
| MCF7 | Sorafenib | 0.04 | uM | LJP6 | 3 | B12 | 72 | hr | 1389 | 5350 | 5740 | 0.9320 | 0.9323 |
| MCF7 | AZD8055 | 10 | uM | LJP6 | 3 | A07 | 72 | hr | 1389 | 1185 | 5740 | 0.2064 | -0.0747 |